{"id":11714,"date":"2022-08-25T13:08:32","date_gmt":"2022-08-25T13:08:32","guid":{"rendered":"https:\/\/dev.sunpharma.com\/?page_id=11714"},"modified":"2026-05-12T16:24:29","modified_gmt":"2026-05-12T10:54:29","slug":"board-meeting-financial-results","status":"publish","type":"page","link":"https:\/\/dev.sunpharma.com\/he\/board-meeting-financial-results\/","title":{"rendered":"Board Meeting &#038; Financial Results"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; fullwidth=&#8221;on&#8221; _builder_version=&#8221;4.16&#8243; background_image=&#8221;https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2021\/03\/investor-banner.jpg&#8221; parallax=&#8221;on&#8221; da_disable_devices=&#8221;off|off|off&#8221; saved_tabs=&#8221;all&#8221; collapsed=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221; da_is_popup=&#8221;off&#8221; da_exit_intent=&#8221;off&#8221; da_has_close=&#8221;on&#8221; da_alt_close=&#8221;off&#8221; da_dark_close=&#8221;off&#8221; da_not_modal=&#8221;on&#8221; da_is_singular=&#8221;off&#8221; da_with_loader=&#8221;off&#8221; da_has_shadow=&#8221;on&#8221;][et_pb_fullwidth_header title=&#8221;Investor Information&#8221; header_fullscreen=&#8221;on&#8221; button_one_url=&#8221;#visionvalues&#8221; button_two_url=&#8221;#codeofconduct&#8221; _builder_version=&#8221;4.16&#8243; title_font=&#8221;|700|||||||&#8221; title_text_color=&#8221;#f7941e&#8221; title_font_size=&#8221;40px&#8221; title_line_height=&#8221;1.2em&#8221; content_font=&#8221;||||||||&#8221; content_text_color=&#8221;#000000&#8243; content_line_height=&#8221;1.8em&#8221; subhead_font=&#8221;||||||||&#8221; subhead_text_color=&#8221;rgba(0,0,0,0.6)&#8221; subhead_line_height=&#8221;1.4em&#8221; background_color=&#8221;rgba(255,255,255,0.7)&#8221; custom_button_one=&#8221;on&#8221; button_one_text_size=&#8221;20px&#8221; button_one_text_color=&#8221;#ffffff&#8221; button_one_bg_color=&#8221;#f7941e&#8221; button_one_border_width=&#8221;0px&#8221; button_one_font=&#8221;|||on|||||&#8221; button_one_use_icon=&#8221;off&#8221; custom_button_two=&#8221;on&#8221; button_two_text_size=&#8221;20px&#8221; button_two_text_color=&#8221;rgba(0,0,0,0.7)&#8221; button_two_bg_color=&#8221;#ffffff&#8221; button_two_border_width=&#8221;0px&#8221; button_two_font=&#8221;|||on|||||&#8221; button_two_use_icon=&#8221;off&#8221; button_two_custom_margin=&#8221;||||false|false&#8221; button_two_custom_margin_tablet=&#8221;&#8221; button_two_custom_margin_phone=&#8221;|||1px|false|false&#8221; button_two_custom_margin_last_edited=&#8221;on|desktop&#8221; button_two_custom_padding=&#8221;||||false|false&#8221; background_layout=&#8221;light&#8221; width=&#8221;50%&#8221; width_tablet=&#8221;&#8221; width_phone=&#8221;100%&#8221; width_last_edited=&#8221;on|phone&#8221; animation_style=&#8221;fade&#8221; animation_duration=&#8221;500ms&#8221; animation_delay=&#8221;300ms&#8221; title_font_tablet=&#8221;&#8221; title_font_phone=&#8221;&#8221; title_font_last_edited=&#8221;on|phone&#8221; content_font_tablet=&#8221;&#8221; content_font_phone=&#8221;&#8221; content_font_last_edited=&#8221;on|phone&#8221; global_colors_info=&#8221;{}&#8221;]At Sun, we remain committed to creating long term value for our shareholders. In line with this philosophy, we will continue to focus on performance and producing consistent returns.[\/et_pb_fullwidth_header][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; background_color=&#8221;#f2f2f2&#8243; custom_padding=&#8221;0px|||||&#8221; da_disable_devices=&#8221;off|off|off&#8221; global_colors_info=&#8221;{}&#8221; da_is_popup=&#8221;off&#8221; da_exit_intent=&#8221;off&#8221; da_has_close=&#8221;on&#8221; da_alt_close=&#8221;off&#8221; da_dark_close=&#8221;off&#8221; da_not_modal=&#8221;on&#8221; da_is_singular=&#8221;off&#8221; da_with_loader=&#8221;off&#8221; da_has_shadow=&#8221;on&#8221;][et_pb_row _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; width=&#8221;90%&#8221; max_width=&#8221;2560px&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h2 style=\"font-weight: 700;\n    font-size: 25px;\n    color: #f7941e!important;\n    line-height: 1.2em;\">Board Meeting &#038; Financial Results<\/h2>\n<p>[\/et_pb_text][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;|600|||||||&#8221; header_3_font=&#8221;|700|||||||&#8221; header_3_text_color=&#8221;#6398d1&#8243; header_3_font_size=&#8221;20px&#8221; header_3_line_height=&#8221;1.2em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>2025 &#8211; 26<\/h3>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_4,1_4,1_4,1_4&#8243; module_class=&#8221;inves_quar&#8221; _builder_version=&#8221;4.16&#8243; width=&#8221;90%&#8221; max_width=&#8221;2560px&#8221; custom_padding=&#8221;||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text module_class=&#8221;earnings-call-recording&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; background_color=&#8221;#fff&#8221; custom_margin=&#8221;||||false|false&#8221; custom_padding=&#8221;10px|10px|10px|10px|true|true&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 1 (Apr-Jun)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2025\/06\/SEintimationforCTW.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Closure of Trading Window<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2025\/07\/SEintimationforBMQ1_2025.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Intimation of Board Meeting<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2025\/07\/BMoutcomeFinal.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Outcome of Board Meeting &#038; Financial Results<\/a>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text content_last_edited=&#8221;off|desktop&#8221; disabled_on=&#8221;off|off|off&#8221; module_class=&#8221;earnings-call-recording&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; background_color=&#8221;#ffffff&#8221; custom_margin=&#8221;||||false|false&#8221; custom_padding=&#8221;10px|10px|10px|10px|true|true&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 2 (Jul-Sep)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2025\/09\/SEintimationforCTW.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Closure of Trading Window<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2025\/10\/SEintimationforBMQ22025.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Intimation of Board Meeting<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2025\/11\/BMOutcomesigned.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Outcome of Board Meeting &#038; Financial Results<\/a>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text content_last_edited=&#8221;off|desktop&#8221; disabled_on=&#8221;off|off|off&#8221; module_class=&#8221;earnings-call-recording&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; background_color=&#8221;#ffffff&#8221; custom_margin=&#8221;||||false|false&#8221; custom_padding=&#8221;10px|10px|10px|10px|true|true&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 3 (Oct-Dec)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2025\/12\/SEintimationforCTW.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Closure of Trading Window<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2026\/01\/SEintimationforBMQ3.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Intimation of Board Meeting<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2026\/01\/BMOutcome.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Outcome of Board Meeting &#038; Financial Results<\/a>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text disabled_on=&#8221;off|off|off&#8221; module_class=&#8221;earnings-call-recording&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; background_color=&#8221;#ffffff&#8221; custom_margin=&#8221;||||false|false&#8221; custom_padding=&#8221;10px|10px|10px|10px|true|true&#8221; hover_enabled=&#8221;0&#8243; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221; sticky_enabled=&#8221;0&#8243;]<\/p>\n<h4>Quarter 4 (Jan-Mar)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2026\/03\/SEintimationforCTW.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Closure of Trading Window<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2026\/05\/SEintimationforBMQ4.pdf\">Intimation of Board Meeting<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=&#8221;4.16&#8243; width=&#8221;90%&#8221; max_width=&#8221;2560px&#8221; custom_padding=&#8221;0px||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;|600|||||||&#8221; header_3_font=&#8221;|700|||||||&#8221; header_3_text_color=&#8221;#6398d1&#8243; header_3_font_size=&#8221;20px&#8221; header_3_line_height=&#8221;1.2em&#8221; custom_margin=&#8221;30px||30px||true|false&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>2024 &#8211; 25<\/h3>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_4,1_4,1_4,1_4&#8243; module_class=&#8221;inves_quar&#8221; _builder_version=&#8221;4.16&#8243; width=&#8221;90%&#8221; max_width=&#8221;2560px&#8221; custom_padding=&#8221;||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text module_class=&#8221;earnings-call-recording&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; background_color=&#8221;#fff&#8221; custom_margin=&#8221;||||false|false&#8221; custom_padding=&#8221;10px|10px|10px|10px|true|true&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 1 (Apr-Jun)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/06\/SEintimationforCTW-3.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Closure of Trading Window<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/07\/SEintimationforBMQ1.pdf\"><span>Intimation of Board Meeting<\/span><\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/08\/BMOutcome.pdf\"><span>Outcome of Board Meeting &#038; Financial Results<\/span><\/a>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text content_last_edited=&#8221;off|desktop&#8221; disabled_on=&#8221;off|off|off&#8221; module_class=&#8221;earnings-call-recording&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; background_color=&#8221;#ffffff&#8221; custom_margin=&#8221;||||false|false&#8221; custom_padding=&#8221;10px|10px|10px|10px|true|true&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 2 (Jul-Sep)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/09\/SEintimationforCTW.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Closure of Trading Window<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/10\/SEintimationforBMQ2.pdf\"><span>Intimation of Board Meeting<\/span><\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/10\/BMOutcomeSD.pdf\"><span>Outcome of Board Meeting &amp; Financial Results<\/span><\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text content_last_edited=&#8221;off|desktop&#8221; disabled_on=&#8221;off|off|off&#8221; module_class=&#8221;earnings-call-recording&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; background_color=&#8221;#ffffff&#8221; custom_margin=&#8221;||||false|false&#8221; custom_padding=&#8221;10px|10px|10px|10px|true|true&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 3 (Oct-Dec)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/12\/SEintimationforCTW.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Closure of Trading Window<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2025\/01\/SEintimationforBMQ3.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Intimation of Board Meeting<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2025\/01\/Outcome-of-BM.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Outcome of Board Meeting &amp; Financial Results<\/a>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text module_class=&#8221;earnings-call-recording&#8221; _builder_version=&#8221;4.27.4&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; background_color=&#8221;#ffffff&#8221; custom_margin=&#8221;||||false|false&#8221; custom_padding=&#8221;10px|10px|10px|10px|true|true&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 4 (Jan-Mar)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2025\/03\/SEintimationforCTW.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Closure of Trading Window<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2025\/05\/SEintimationforBMQ4.pdf\" target=\"_blank\" rel=\"noopener noreferrer\"> Intimation of Board Meeting<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2025\/05\/BMOutcomefinal.pdf\" target=\"_blank\" rel=\"noopener noreferrer\"> Outcome of Board Meeting &#038; Financial Results<\/a>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=&#8221;4.16&#8243; width=&#8221;90%&#8221; max_width=&#8221;2560px&#8221; custom_padding=&#8221;0px||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;|600|||||||&#8221; header_3_font=&#8221;|700|||||||&#8221; header_3_text_color=&#8221;#6398d1&#8243; header_3_font_size=&#8221;20px&#8221; header_3_line_height=&#8221;1.2em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=&#8221;4.16&#8243; width=&#8221;90%&#8221; max_width=&#8221;2560px&#8221; custom_padding=&#8221;0px||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;|600|||||||&#8221; header_3_font=&#8221;|700|||||||&#8221; header_3_text_color=&#8221;#6398d1&#8243; header_3_font_size=&#8221;20px&#8221; header_3_line_height=&#8221;1.2em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>2023 &#8211; 24<\/h3>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_4,1_4,1_4,1_4&#8243; module_class=&#8221;inves_quar&#8221; _builder_version=&#8221;4.16&#8243; width=&#8221;90%&#8221; max_width=&#8221;2560px&#8221; custom_padding=&#8221;||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text module_class=&#8221;earnings-call-recording&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; background_color=&#8221;#fff&#8221; custom_margin=&#8221;||||false|false&#8221; custom_padding=&#8221;10px|10px|10px|10px|true|true&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 1 (Apr-Jun)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2023\/06\/SEIntimationforwindowclosure.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Closure of Trading Window<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2023\/07\/BMintimationsigned.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Intimation of Board Meeting<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2023\/08\/OutcomeSigned-2.pdf\" target=\"_blank\" rel=\"noopener noreferrer\"><span>Outcome of Board Meeting &amp; Financial Results<\/span><\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text module_class=&#8221;earnings-call-recording&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; background_color=&#8221;#ffffff&#8221; custom_margin=&#8221;||||false|false&#8221; custom_padding=&#8221;10px|10px|10px|10px|true|true&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 2 (Jul-Sep)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2023\/09\/SESigned.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Closure of Trading Window<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2023\/10\/IntimationSigned-29.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Intimation of Board Meeting<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2023\/11\/OutcomeFinalSigned.pdf\" target=\"_blank\" rel=\"noopener noreferrer\"><span>Outcome of Board Meeting &amp; Financial Results<\/span><\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text module_class=&#8221;earnings-call-recording&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; background_color=&#8221;#ffffff&#8221; custom_margin=&#8221;||||false|false&#8221; custom_padding=&#8221;10px|10px|10px|10px|true|true&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 3 (Oct-Dec)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2023\/12\/SEintimationforCTW.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Closure of Trading Window<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/01\/SEintimationforBM.pdf\">Intimation of Board Meeting<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/01\/UFRQ3-2023-24.pdf\">Outcome of Board Meeting &amp; Financial Results<\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text module_class=&#8221;earnings-call-recording&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; background_color=&#8221;#ffffff&#8221; custom_margin=&#8221;||||false|false&#8221; custom_padding=&#8221;10px|10px|10px|10px|true|true&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 4 (Jan-Mar)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/03\/SEintimationforCTW-2.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Closure of Trading Window<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/05\/SEintimationforBMQ4.pdf\" target=\"_blank\" rel=\"noopener noreferrer\"><span>Intimation of Board Meeting<\/span><\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2024\/05\/BMOutcome.pdf\"><span>Outcome of Board Meeting &amp; Financial Results<\/span><\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=&#8221;4.16&#8243; width=&#8221;90%&#8221; max_width=&#8221;2560px&#8221; custom_padding=&#8221;0px||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;|600|||||||&#8221; header_3_font=&#8221;|700|||||||&#8221; header_3_text_color=&#8221;#6398d1&#8243; header_3_font_size=&#8221;20px&#8221; header_3_line_height=&#8221;1.2em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=&#8221;4.16&#8243; width=&#8221;90%&#8221; max_width=&#8221;2560px&#8221; custom_padding=&#8221;0px||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; header_font=&#8221;|600|||||||&#8221; header_3_font=&#8221;|700|||||||&#8221; header_3_text_color=&#8221;#6398d1&#8243; header_3_font_size=&#8221;20px&#8221; header_3_line_height=&#8221;1.2em&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h3>2022 &#8211; 23<\/h3>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=&#8221;1_4,1_4,1_4,1_4&#8243; module_class=&#8221;inves_quar&#8221; _builder_version=&#8221;4.16&#8243; width=&#8221;90%&#8221; max_width=&#8221;2560px&#8221; custom_padding=&#8221;||0px||false|false&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text module_class=&#8221;earnings-call-recording&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; background_color=&#8221;#fff&#8221; custom_margin=&#8221;||||false|false&#8221; custom_padding=&#8221;10px|10px|10px|10px|true|true&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 1 (Apr-Jun)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2022\/06\/Closure-of-Trading-Window-Q1-2022-23.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Closure of Trading Window<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2022\/07\/SPIL-SE-Intimation-of-BM_July_2022_Signed.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Intimation of Board Meeting<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2022\/07\/Outcome-of-BM-29072022.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Outcome of Board Meeting &amp; Financial Results<\/a>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text module_class=&#8221;earnings-call-recording&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; background_color=&#8221;#fff&#8221; custom_margin=&#8221;||||false|false&#8221; custom_padding=&#8221;10px|10px|10px|10px|true|true&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 2 (Jul\u2013Sep)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2022\/09\/BSE-NSE-WINDOW-CLOSURE-NOTICE-Q2-2022-23signed.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Closure of Trading Window<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2022\/10\/quarter-2-intimation-of-board-meeting.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Intimation of Board Meeting<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2022\/11\/IntimationSigned-4.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Outcome of Board Meeting &amp; Financial Results<\/a>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text module_class=&#8221;earnings-call-recording&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; background_color=&#8221;#fff&#8221; custom_margin=&#8221;||||false|false&#8221; custom_padding=&#8221;10px|10px|10px|10px|true|true&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 3 (Oct-Dec)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2022\/12\/WINDOW-CLOSURE-NOTICE-Q3-20200-23.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Closure of Trading Window<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2023\/01\/IntimationSigned-6.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Intimation of Board Meeting<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2023\/01\/IntimationSigned-8.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Outcome of Board Meeting &amp; Financial Results<\/a>[\/et_pb_text][\/et_pb_column][et_pb_column type=&#8221;1_4&#8243; _builder_version=&#8221;4.16&#8243; global_colors_info=&#8221;{}&#8221;][et_pb_text module_class=&#8221;earnings-call-recording&#8221; _builder_version=&#8221;4.16&#8243; _module_preset=&#8221;default&#8221; text_line_height=&#8221;1.8em&#8221; header_3_font=&#8221;|600|||||||&#8221; header_4_font=&#8221;|700|||||||&#8221; header_4_text_color=&#8221;#000000&#8243; header_4_line_height=&#8221;1.4em&#8221; background_color=&#8221;#fff&#8221; custom_margin=&#8221;||||false|false&#8221; custom_padding=&#8221;10px|10px|10px|10px|true|true&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<h4>Quarter 4 (Jan-Mar)<\/h4>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2023\/03\/Intimationsigned-18.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Closure of Trading Window<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2023\/05\/IntimationSigned-21.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Intimation of Board Meeting<\/a><\/p>\n<p><a href=\"https:\/\/dev.sunpharma.com\/wp-content\/uploads\/2023\/05\/OutcomeSigned.pdf\" target=\"_blank\" rel=\"noopener noreferrer\"><span>Outcome of Board Meeting &amp; Financial Results<\/span><\/a><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>At Sun, we remain committed to creating long term value for our shareholders. In line with this philosophy, we will continue to focus on performance and producing consistent returns.Board Meeting &#038; Financial Results2025 &#8211; 26Quarter 1 (Apr-Jun) Closure of Trading Window Intimation of Board Meeting Outcome of Board Meeting &#038; Financial ResultsQuarter 2 (Jul-Sep) Closure [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","inline_featured_image":false,"_uf_show_specific_survey":0,"_uf_disable_surveys":false,"footnotes":""},"class_list":["post-11714","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Board Meeting &amp; Financial Results - Sun Pharmaceutical Industries Ltd.<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/dev.sunpharma.com\/he\/board-meeting-financial-results\/\" \/>\n<meta property=\"og:locale\" content=\"he_IL\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Board Meeting &amp; Financial Results - Sun Pharmaceutical Industries Ltd.\" \/>\n<meta property=\"og:description\" content=\"At Sun, we remain committed to creating long term value for our shareholders. In line with this philosophy, we will continue to focus on performance and producing consistent returns.Board Meeting &amp; Financial Results2025 - 26Quarter 1 (Apr-Jun) Closure of Trading Window Intimation of Board Meeting Outcome of Board Meeting &amp; Financial ResultsQuarter 2 (Jul-Sep) Closure [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/dev.sunpharma.com\/he\/board-meeting-financial-results\/\" \/>\n<meta property=\"og:site_name\" content=\"Sun Pharmaceutical Industries Ltd.\" \/>\n<meta property=\"article:modified_time\" content=\"2026-05-12T10:54:29+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/dev.sunpharma.com\\\/board-meeting-financial-results\\\/\",\"url\":\"https:\\\/\\\/dev.sunpharma.com\\\/board-meeting-financial-results\\\/\",\"name\":\"Board Meeting & Financial Results - Sun Pharmaceutical Industries Ltd.\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/dev.sunpharma.com\\\/#website\"},\"datePublished\":\"2022-08-25T13:08:32+00:00\",\"dateModified\":\"2026-05-12T10:54:29+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/dev.sunpharma.com\\\/board-meeting-financial-results\\\/#breadcrumb\"},\"inLanguage\":\"he-IL\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/dev.sunpharma.com\\\/board-meeting-financial-results\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/dev.sunpharma.com\\\/board-meeting-financial-results\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/dev.sunpharma.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Board Meeting &#038; Financial Results\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/dev.sunpharma.com\\\/#website\",\"url\":\"https:\\\/\\\/dev.sunpharma.com\\\/\",\"name\":\"Sun Pharmaceutical Industries Ltd.\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/dev.sunpharma.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"he-IL\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Board Meeting & Financial Results - Sun Pharmaceutical Industries Ltd.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/dev.sunpharma.com\/he\/board-meeting-financial-results\/","og_locale":"he_IL","og_type":"article","og_title":"Board Meeting & Financial Results - Sun Pharmaceutical Industries Ltd.","og_description":"At Sun, we remain committed to creating long term value for our shareholders. In line with this philosophy, we will continue to focus on performance and producing consistent returns.Board Meeting & Financial Results2025 - 26Quarter 1 (Apr-Jun) Closure of Trading Window Intimation of Board Meeting Outcome of Board Meeting & Financial ResultsQuarter 2 (Jul-Sep) Closure [&hellip;]","og_url":"https:\/\/dev.sunpharma.com\/he\/board-meeting-financial-results\/","og_site_name":"Sun Pharmaceutical Industries Ltd.","article_modified_time":"2026-05-12T10:54:29+00:00","twitter_card":"summary_large_image","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/dev.sunpharma.com\/board-meeting-financial-results\/","url":"https:\/\/dev.sunpharma.com\/board-meeting-financial-results\/","name":"Board Meeting & Financial Results - Sun Pharmaceutical Industries Ltd.","isPartOf":{"@id":"https:\/\/dev.sunpharma.com\/#website"},"datePublished":"2022-08-25T13:08:32+00:00","dateModified":"2026-05-12T10:54:29+00:00","breadcrumb":{"@id":"https:\/\/dev.sunpharma.com\/board-meeting-financial-results\/#breadcrumb"},"inLanguage":"he-IL","potentialAction":[{"@type":"ReadAction","target":["https:\/\/dev.sunpharma.com\/board-meeting-financial-results\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/dev.sunpharma.com\/board-meeting-financial-results\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/dev.sunpharma.com\/"},{"@type":"ListItem","position":2,"name":"Board Meeting &#038; Financial Results"}]},{"@type":"WebSite","@id":"https:\/\/dev.sunpharma.com\/#website","url":"https:\/\/dev.sunpharma.com\/","name":"Sun Pharmaceutical Industries Ltd.","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/dev.sunpharma.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"he-IL"}]}},"_links":{"self":[{"href":"https:\/\/dev.sunpharma.com\/he\/wp-json\/wp\/v2\/pages\/11714","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dev.sunpharma.com\/he\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/dev.sunpharma.com\/he\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/dev.sunpharma.com\/he\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/dev.sunpharma.com\/he\/wp-json\/wp\/v2\/comments?post=11714"}],"version-history":[{"count":54,"href":"https:\/\/dev.sunpharma.com\/he\/wp-json\/wp\/v2\/pages\/11714\/revisions"}],"predecessor-version":[{"id":19196,"href":"https:\/\/dev.sunpharma.com\/he\/wp-json\/wp\/v2\/pages\/11714\/revisions\/19196"}],"wp:attachment":[{"href":"https:\/\/dev.sunpharma.com\/he\/wp-json\/wp\/v2\/media?parent=11714"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}